Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIXT | AZN | AMGN | GILD | VRTX |
| Company | Bioxytran Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0455 | 93.03 | 340.81 | 139.08 | 471.18 |
| High | 0.0485 | 93.51 | 345.50 | 142.20 | 475.67 |
| Low | 0.0426 | 92.46 | 338.07 | 138.65 | 468.00 |
| Latest | 0.0426 | 92.77 | 341.88 | 141.95 | 469.90 |
| Change | -0.0044 | +0.18 | -1.06 | +2.40 | -5.78 |
| % Change | -9.36% | +0.19% | -0.31% | +1.72% | -1.22% |
| Volume | 83,100 | 5,555,000 | 2,522,700 | 9,460,199 | 1,190,400 |
| 20-Day Average Volume | 196,635 | 9,447,565 | 2,748,520 | 7,751,890 | 1,533,625 |
| Previous Close | 0.0470 | 92.59 | 342.94 | 139.55 | 475.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0615 | 93.40 | 335.51 | 128.11 | 462.28 |
| 20-Day Raw Stochastic | 0.00% | 49.93% | 67.55% | 99.01% | 69.89% |
| 20-Day Relative Strength | 32.82 | 51.71 | 56.16 | 69.44 | 56.24 |
| Weighted Alpha | -81.02 | +34.12 | +23.15 | +50.21 | +6.69 |
| Today's Opinion | 88% Sell | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 8% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.24% since 01/23/26 | -0.19% since 01/23/26 | -0.83% since 01/23/26 | +4.43% since 01/23/26 | +0.32% since 01/23/26 |
| Low | 0.0426 on 01/30/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 133.69 on 01/26/26 | 468.00 on 01/30/26 |
| High | 0.0580 on 01/26/26 | 96.18 on 01/27/26 | 353.25 on 01/27/26 | 142.20 on 01/30/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | -43.95% since 12/30/25 | +0.28% since 12/30/25 | +4.01% since 12/30/25 | +15.24% since 12/30/25 | +3.56% since 12/30/25 |
| Low | 0.0426 on 01/30/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 0.0758 on 12/31/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 142.20 on 01/30/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -39.14% since 10/30/25 | +12.67% since 10/30/25 | +17.08% since 10/30/25 | +19.85% since 10/30/25 | +11.91% since 10/30/25 |
| Low | 0.0426 on 01/30/26 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 0.0949 on 12/26/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 142.20 on 01/30/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -52.88% since 07/30/25 | +21.13% since 07/30/25 | +13.44% since 07/30/25 | +23.69% since 07/30/25 | +0.16% since 07/30/25 |
| Low | 0.0391 on 10/24/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 0.0997 on 08/01/25 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 142.20 on 01/30/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,083 | 287,197,120 | 184,666,688 | 173,136,896 | 120,689,048 |
| Shares Outstanding, K | 108,148 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -2,370,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -280,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.15 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/02/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.40 | 15.65 | 17.06 | 31.22 |